Playback speed
×
Share post
Share post at current time
0:00
/
0:00
Transcript

Loophole in Dutch and European legislation

Video presentation by Willem Engel

Link to video on Rumble

Video Description:

Looking at all things that are not in order, we start looking for fraud in the authorization process. In a normal process the batches would have been recalled and the Marketing authorization would have been revoked. So why did it go through in the first place? We identify 3 regulations that were crucial to circumvent the safety standards and checks and balances. 2006/507 grating a CMA in case of a public health emergency AND the absence of a treatment resulting in an unmet medical need. 2020/1043 circumventing regulations concerning GMO's and lastly 2021/756 changing the classification system by including gene-therapy into the vaccine category, bypassing numerous safety tests. We also identify key players who streamlined this effort in subverting the law in order to get illegal drugs on the European market.

Due Diligence and Art
Due Diligence by Sasha Latypova Podcast
Uncovering Fraud in Pharmaceutical R&D and Manufacturing